Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five ratings firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price […]
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five ratings firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price […]
